Stem cells for the treatment of glioblastoma: a 20-year perspective von Calinescu, Anda-Alexandra, Kauss, McKenzie C, Sultan, Zain, Al-Holou, Wajd N, O’Shea, Sue K

Volltext

NCOG-27. HIGHER LEVELS OF SERUM ICAM-1 AND IL-10 ARE ASSOCIATED WITH COGNITIVE DYSFUNCTION IN BOTH IDH-WILDTYPE AND IDH-MUTANT GLIOMA von Guedes, Vivian A, Mendoza, Tito, Slattery, Kaitlynn, Kauss, McKenzie C, Raval, Dhaivat, Hsieh, Emory, Wright, Michelle L, Davis, Tara S, Choi, Ann, Reinhart, Kimberly, Miller, Hope, Vera, Elizabeth, Penas-Prado, Marta, Gilbert, Mark R, Armstrong, Terri S

Volltext

NCOG-28. SERUM PROTEIN BIOMARKERS LINKED TO NEURODEGENERATIVE PROCESSES ARE ELEVATED IN GLIOMA PATIENTS AND ASSOCIATED WITH SEVERITY OF NEUROLOGIC SYMPTOMS von Hsieh, Emory, Mendoza, Tito, Raval, Dhaivat, Kauss, McKenzie C, Slattery, Kaitlynn, Wright, Michelle L, Davis, Tara S, Choi, Ann, Reinhart, Kimberly, Miller, Hope, Vera, Elizabeth, Penas-Prado, Marta, Gilbert, Mark R, Armstrong, Terri S, Guedes, Vivian A

Volltext

Supplementary Table 1. Stem cells for the treatment of glioblastoma: a 20-year perspective von Calinescu, Anda-Alexandra, Kauss, McKenzie C, Sultan, Zain, Al-Holou, Wajd N, O’Shea, Sue K

Volltext bestellen

Supplementary Table 2. Stem cells for the treatment of glioblastoma: a 20-year perspective von Calinescu, Anda-Alexandra, Kauss, McKenzie C, Sultan, Zain, Al-Holou, Wajd N, O’Shea, Sue K

Volltext bestellen